Literature DB >> 4562464

Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children.

L M Greenberg, M A Deem, S McMahon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562464     DOI: 10.1176/ajp.129.5.532

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

2.  Activity level: a comparison between actometer scores and observer ratings.

Authors:  T M Stevens; M J Kupst; B G Suran; J L Schulman
Journal:  J Abnorm Child Psychol       Date:  1978-06

3.  Growth and cardiovascular measures in hyperactive individuals as young adults and in matched normal controls.

Authors:  L Hechtman; G Weiss; T Perlman
Journal:  Can Med Assoc J       Date:  1978-05-20       Impact factor: 8.262

4.  Format effects in two teacher rating scales of hyperactivity.

Authors:  J Sandoval
Journal:  J Abnorm Child Psychol       Date:  1981-06

5.  Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.

Authors:  Drew E Winters; Sadaaki Fukui; Ellen Leibenluft; Leslie A Hulvershorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-04-30       Impact factor: 2.576

6.  Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses.

Authors:  G L Brown; R D Hunt; M H Ebert; W E Bunney; I J Kopin
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

7.  Individual responses to methylphenidate and caffeine in children with minimal brain dysfunction.

Authors:  B D Garfinkel; C D Webster; L Sloman
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.